EssilorLuxottica has announced that its Essilor Stellest lenses, developed to slow myopia progression in children, have received approval from the U.S. Food and Drug Administration (FDA). With this approval, Stellest becomes the first and only eyeglass lenses to gain market authorization in the United States. The company plans to make this innovation, developed through years of research and development, available to users in the near future through U.S.-based eye care professionals. FDA approval is seen as a significant milestone that reinforces EssiLux’s global leadership in myopia management.

November 2025